Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	TENT4B TENT4A SNRK IP6K1 SIK3 TEP1 MAP3K6 CDK10 MAP3K5 SBK1 PHKA2 BMPR2 KARS1 GUCY2C PDIK1L NRK EIF2AK1 MAP4K2 PINK1 CKMT1A	7.64e-07	938	120	20	GO:0016772
GeneOntologyMolecularFunction	protein serine/threonine kinase activity	SNRK SIK3 MAP3K6 CDK10 MAP3K5 SBK1 PHKA2 BMPR2 PDIK1L NRK EIF2AK1 MAP4K2 PINK1	2.90e-06	446	120	13	GO:0004674
GeneOntologyMolecularFunction	protein serine kinase activity	SNRK SIK3 MAP3K6 CDK10 MAP3K5 SBK1 PDIK1L NRK EIF2AK1 MAP4K2 PINK1	1.22e-05	363	120	11	GO:0106310
GeneOntologyMolecularFunction	kinase activity	SNRK IP6K1 SIK3 MAP3K6 CDK10 MAP3K5 SBK1 PHKA2 BMPR2 GUCY2C PDIK1L NRK EIF2AK1 MAP4K2 PINK1 CKMT1A	1.37e-05	764	120	16	GO:0016301
GeneOntologyMolecularFunction	protein kinase activity	SNRK SIK3 MAP3K6 CDK10 MAP3K5 SBK1 PHKA2 BMPR2 GUCY2C PDIK1L NRK EIF2AK1 MAP4K2 PINK1	1.51e-05	600	120	14	GO:0004672
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	SNRK IP6K1 SIK3 MAP3K6 CDK10 MAP3K5 SBK1 PHKA2 BMPR2 GUCY2C PDIK1L NRK EIF2AK1 MAP4K2 PINK1	2.31e-05	709	120	15	GO:0016773
GeneOntologyMolecularFunction	catalytic activity, acting on DNA	TENT4B ERCC6L CHD3 CHD1L MSH4 TEP1 LIG1 SMARCA1 DNMT1	2.96e-05	262	120	9	GO:0140097
GeneOntologyMolecularFunction	glutamine-fructose-6-phosphate transaminase (isomerizing) activity	GFPT1 GFPT2	3.58e-05	2	120	2	GO:0004360
GeneOntologyMolecularFunction	ATP-dependent chromatin remodeler activity	ERCC6L CHD3 CHD1L SMARCA1	7.03e-05	37	120	4	GO:0140658
GeneOntologyMolecularFunction	L-glutamine aminotransferase activity	GFPT1 GFPT2	1.07e-04	3	120	2	GO:0070548
GeneOntologyMolecularFunction	protein transporter activity	PEX10 BCS1L LRP2 DNAJB2	1.16e-04	42	120	4	GO:0140318
GeneOntologyMolecularFunction	serine C-palmitoyltransferase activity	SPTLC3 SPTLC2	3.54e-04	5	120	2	GO:0004758
GeneOntologyMolecularFunction	C-palmitoyltransferase activity	SPTLC3 SPTLC2	3.54e-04	5	120	2	GO:0016454
GeneOntologyMolecularFunction	protein-folding chaperone binding	HLA-A HLA-G DNAJB3 LRP2 DNAJB5 DNAJB2	4.29e-04	161	120	6	GO:0051087
GeneOntologyMolecularFunction	catalytic activity, acting on a nucleic acid	TENT4B ERCC6L DDX60 CHD3 CHD1L MSH4 TEP1 LIG1 KARS1 SMARCA1 DBR1 DNMT1	5.11e-04	645	120	12	GO:0140640
GeneOntologyMolecularFunction	eukaryotic translation initiation factor 2alpha kinase activity	PDIK1L EIF2AK1	5.29e-04	6	120	2	GO:0004694
GeneOntologyMolecularFunction	alkaline phosphatase activity	CILP ALPG	5.29e-04	6	120	2	GO:0004035
GeneOntologyMolecularFunction	guanylyltransferase activity	TENT4B TENT4A	7.37e-04	7	120	2	GO:0070568
GeneOntologyMolecularFunction	adenylyltransferase activity	TENT4B TENT4A KARS1	8.41e-04	31	120	3	GO:0070566
GeneOntologyMolecularFunction	extracellular matrix binding	SPP1 ADAMTS5 FBLN2 ADAMTS15	9.81e-04	73	120	4	GO:0050840
GeneOntologyMolecularFunction	ATP-dependent activity, acting on DNA	ERCC6L CHD3 CHD1L MSH4 SMARCA1	1.02e-03	127	120	5	GO:0008094
GeneOntologyMolecularFunction	CD8 receptor binding	HLA-A HLA-G	1.25e-03	9	120	2	GO:0042610
GeneOntologyMolecularFunction	TAP complex binding	HLA-A HLA-G	1.25e-03	9	120	2	GO:0062061
GeneOntologyMolecularFunction	metallopeptidase activity	MMP28 ADAMTS5 NPEPL1 ADAM10 ADAMTS15 CNDP2	1.33e-03	200	120	6	GO:0008237
GeneOntologyMolecularFunction	TAP1 binding	HLA-A HLA-G	1.56e-03	10	120	2	GO:0046978
GeneOntologyMolecularFunction	TAP2 binding	HLA-A HLA-G	1.56e-03	10	120	2	GO:0046979
GeneOntologyMolecularFunction	TAP binding	HLA-A HLA-G	1.56e-03	10	120	2	GO:0046977
GeneOntologyMolecularFunction	metallodipeptidase activity	ADAM10 CNDP2	1.56e-03	10	120	2	GO:0070573
GeneOntologyMolecularFunction	beta-2-microglobulin binding	HLA-A HLA-G	2.27e-03	12	120	2	GO:0030881
GeneOntologyMolecularFunction	poly(A) RNA polymerase activity	TENT4B TENT4A	2.27e-03	12	120	2	GO:1990817
GeneOntologyMolecularFunction	helicase activity	ERCC6L DDX60 CHD3 CHD1L SMARCA1	2.67e-03	158	120	5	GO:0004386
GeneOntologyMolecularFunction	nucleosome binding	RCC1 CHD1L SMARCA1 HDAC2	2.90e-03	98	120	4	GO:0031491
GeneOntologyBiologicalProcess	polyadenylation-dependent RNA catabolic process	TENT4B TENT4A	3.25e-05	2	118	2	GO:0043633
GeneOntologyBiologicalProcess	polyadenylation-dependent ncRNA catabolic process	TENT4B TENT4A	3.25e-05	2	118	2	GO:0043634
GeneOntologyBiologicalProcess	negative regulation of cell differentiation involved in phenotypic switching	FGF9 DNMT1	3.25e-05	2	118	2	GO:1905916
GeneOntologyBiologicalProcess	negative regulation of phenotypic switching	FGF9 DNMT1	3.25e-05	2	118	2	GO:1900240
GeneOntologyBiologicalProcess	negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching	FGF9 DNMT1	3.25e-05	2	118	2	GO:1905931
GeneOntologyBiologicalProcess	polyol metabolic process	SPTLC3 SPTLC2 IP6K1 MECP2 MYOF LRP2	7.60e-05	123	118	6	GO:0019751
GeneOntologyBiologicalProcess	negative regulation of nuclear-transcribed mRNA poly(A) tail shortening	TENT4B TENT4A	9.70e-05	3	118	2	GO:0060212
Domain	Pkinase	SNRK SIK3 MAP3K6 CDK10 MAP3K5 SBK1 BMPR2 GUCY2C PDIK1L NRK EIF2AK1 MAP4K2 PINK1	5.83e-07	381	114	13	PF00069
Domain	Ser/Thr_kinase_AS	SNRK SIK3 MAP3K6 CDK10 MAP3K5 SBK1 BMPR2 PDIK1L NRK EIF2AK1 MAP4K2 PINK1	1.90e-06	357	114	12	IPR008271
Domain	PROTEIN_KINASE_ST	SNRK SIK3 MAP3K6 CDK10 MAP3K5 SBK1 BMPR2 PDIK1L NRK EIF2AK1 MAP4K2 PINK1	2.20e-06	362	114	12	PS00108
Domain	Prot_kinase_dom	SNRK SIK3 MAP3K6 CDK10 MAP3K5 SBK1 BMPR2 GUCY2C PDIK1L NRK EIF2AK1 MAP4K2 PINK1	9.04e-06	489	114	13	IPR000719
Domain	PROTEIN_KINASE_DOM	SNRK SIK3 MAP3K6 CDK10 MAP3K5 SBK1 BMPR2 GUCY2C PDIK1L NRK EIF2AK1 MAP4K2 PINK1	9.86e-06	493	114	13	PS50011
Domain	S_TKc	SNRK SIK3 MAP3K6 CDK10 MAP3K5 SBK1 PDIK1L NRK EIF2AK1 MAP4K2 PINK1	1.25e-05	359	114	11	SM00220
Domain	PROTEIN_KINASE_ATP	SNRK SIK3 MAP3K6 CDK10 MAP3K5 SBK1 BMPR2 PDIK1L NRK EIF2AK1 MAP4K2 PINK1	2.41e-05	459	114	12	PS00107
Domain	Kinase-like_dom	SNRK SIK3 MAP3K6 CDK10 MAP3K5 SBK1 BMPR2 GUCY2C PDIK1L NRK EIF2AK1 MAP4K2 PINK1	2.67e-05	542	114	13	IPR011009
Domain	CSTF2_hinge	CSTF2 CSTF2T	3.69e-05	2	114	2	PF14327
Domain	CSTF_C	CSTF2 CSTF2T	3.69e-05	2	114	2	PF14304
Domain	GlmS_trans	GFPT1 GFPT2	3.69e-05	2	114	2	IPR005855
Domain	CSTF2_hinge	CSTF2 CSTF2T	3.69e-05	2	114	2	IPR025742
Domain	SIS	GFPT1 GFPT2	3.69e-05	2	114	2	PF01380
Domain	CSTF_C	CSTF2 CSTF2T	3.69e-05	2	114	2	IPR026896
Domain	SNF2_N	ERCC6L CHD3 CHD1L SMARCA1	4.15e-05	32	114	4	IPR000330
Domain	SNF2_N	ERCC6L CHD3 CHD1L SMARCA1	4.15e-05	32	114	4	PF00176
Domain	CNH	VPS39 NRK MAP4K2	7.68e-05	14	114	3	SM00036
Domain	CNH	VPS39 NRK MAP4K2	9.55e-05	15	114	3	PF00780
Domain	CNH	VPS39 NRK MAP4K2	9.55e-05	15	114	3	PS50219
Domain	CNH_dom	VPS39 NRK MAP4K2	9.55e-05	15	114	3	IPR001180
Domain	Protein_kinase_ATP_BS	SNRK SIK3 MAP3K6 CDK10 MAP3K5 BMPR2 PDIK1L NRK EIF2AK1 MAP4K2	1.10e-04	379	114	10	IPR017441
Domain	SIS	GFPT1 GFPT2	1.10e-04	3	114	2	PS51464
Domain	DUF4071	MAP3K6 MAP3K5	1.10e-04	3	114	2	PF13281
Domain	SIS	GFPT1 GFPT2	1.10e-04	3	114	2	IPR001347
Domain	DUF4071	MAP3K6 MAP3K5	1.10e-04	3	114	2	IPR025136
Domain	-	MPP2 MYO1E ERCC6L DDX60 CHD3 CHD1L MSH4 TEP1 BCS1L DNAH1 DAP3 SBNO1 SMARCA1 DNAH5	1.80e-04	746	114	14	3.40.50.300
Domain	GATASE_TYPE_2	GFPT1 GFPT2	3.65e-04	5	114	2	PS51278
Domain	GATase_2_dom	GFPT1 GFPT2	3.65e-04	5	114	2	IPR017932
Domain	Helicase_C	ERCC6L DDX60 CHD3 CHD1L SMARCA1	5.03e-04	107	114	5	PF00271
Domain	HELICc	ERCC6L DDX60 CHD3 CHD1L SMARCA1	5.03e-04	107	114	5	SM00490
Domain	Helicase_C	ERCC6L DDX60 CHD3 CHD1L SMARCA1	5.24e-04	108	114	5	IPR001650
Domain	AA_TRANSFER_CLASS_2	SPTLC3 SPTLC2	5.45e-04	6	114	2	PS00599
Domain	Aminotrans_II_pyridoxalP_BS	SPTLC3 SPTLC2	5.45e-04	6	114	2	IPR001917
Domain	HELICASE_CTER	ERCC6L DDX60 CHD3 CHD1L SMARCA1	5.47e-04	109	114	5	PS51194
Domain	HELICASE_ATP_BIND_1	ERCC6L DDX60 CHD3 CHD1L SMARCA1	5.47e-04	109	114	5	PS51192
Domain	DEXDc	ERCC6L DDX60 CHD3 CHD1L SMARCA1	5.47e-04	109	114	5	SM00487
Domain	Helicase_ATP-bd	ERCC6L DDX60 CHD3 CHD1L SMARCA1	5.70e-04	110	114	5	IPR014001
Domain	DnaJ_domain_CS	DNAJB3 DNAJB5 DNAJB2	5.82e-04	27	114	3	IPR018253
Domain	P-loop_NTPase	MPP2 MYO1E ERCC6L DDX60 CHD3 CHD1L MSH4 TEP1 BCS1L DNAH1 DAP3 SBNO1 SMARCA1 DNAH5	6.55e-04	848	114	14	IPR027417
Domain	PAP_assoc	TENT4B TENT4A	7.60e-04	7	114	2	PF03828
Domain	PAP_assoc	TENT4B TENT4A	7.60e-04	7	114	2	IPR002058
Domain	EGF_LAM_2	HSPG2 LAMA5 USH2A	7.97e-04	30	114	3	PS50027
Domain	EGF_LAM_1	HSPG2 LAMA5 USH2A	7.97e-04	30	114	3	PS01248
Domain	LAMININ_IVA	HSPG2 LAMA5	1.01e-03	8	114	2	PS51115
Domain	Laminin_B	HSPG2 LAMA5	1.01e-03	8	114	2	PF00052
Domain	LamB	HSPG2 LAMA5	1.01e-03	8	114	2	SM00281
Domain	Laminin_IV	HSPG2 LAMA5	1.01e-03	8	114	2	IPR000034
Domain	EGF_Lam	HSPG2 LAMA5 USH2A	1.26e-03	35	114	3	SM00180
Domain	Laminin_EGF	HSPG2 LAMA5 USH2A	1.26e-03	35	114	3	PF00053
Domain	-	MMP28 ADAMTS5 ADAM10 ADAMTS15	1.53e-03	81	114	4	3.40.390.10
Domain	MetalloPept_cat_dom	MMP28 ADAMTS5 ADAM10 ADAMTS15	1.53e-03	81	114	4	IPR024079
Domain	DEAH_ATP_HELICASE	CHD3 CHD1L SMARCA1	1.60e-03	38	114	3	PS00690
Domain	LAM_G_DOMAIN	HSPG2 LAMA5 USH2A	1.60e-03	38	114	3	PS50025
Domain	Laminin_EGF	HSPG2 LAMA5 USH2A	1.60e-03	38	114	3	IPR002049
Domain	Pep_M12B_propep	ADAMTS5 ADAM10 ADAMTS15	1.72e-03	39	114	3	PF01562
Domain	Peripla_BP_I	GRIA2 GUCY2C GRIN3B	1.72e-03	39	114	3	IPR028082
Domain	Peptidase_M12B_N	ADAMTS5 ADAM10 ADAMTS15	1.72e-03	39	114	3	IPR002870
Domain	RRM_1	RBMXL3 RBM45 CSTF2 RBM8A CSTF2T ENOX2	1.75e-03	208	114	6	PF00076
Domain	DISINTEGRIN_1	ADAMTS5 ADAM10 ADAMTS15	1.86e-03	40	114	3	PS00427
Domain	Reprolysin	ADAMTS5 ADAM10 ADAMTS15	1.86e-03	40	114	3	PF01421
Domain	Laminin_G_2	HSPG2 LAMA5 USH2A	1.86e-03	40	114	3	PF02210
Domain	ADAM_MEPRO	ADAMTS5 ADAM10 ADAMTS15	1.86e-03	40	114	3	PS50215
Domain	DISINTEGRIN_2	ADAMTS5 ADAM10 ADAMTS15	1.86e-03	40	114	3	PS50214
Domain	Peptidase_M12B	ADAMTS5 ADAM10 ADAMTS15	1.86e-03	40	114	3	IPR001590
Domain	NTP_transf_2	TENT4B TENT4A	1.96e-03	11	114	2	PF01909
Domain	Polymerase_NTP_transf_dom	TENT4B TENT4A	1.96e-03	11	114	2	IPR002934
Domain	CYSTEINE_SWITCH	MMP28 ADAM10 ADAMTS15	1.99e-03	41	114	3	PS00546
Domain	Disintegrin_dom	ADAMTS5 ADAM10 ADAMTS15	1.99e-03	41	114	3	IPR001762
Domain	RRM	RBMXL3 RBM45 CSTF2 RBM8A CSTF2T ENOX2	2.16e-03	217	114	6	SM00360
Domain	Pept_M10_metallopeptidase	MMP28 ADAM10 ADAMTS15	2.29e-03	43	114	3	IPR001818
Domain	UBA	RNF31 SNRK SIK3	2.44e-03	44	114	3	IPR015940
Domain	LamG	HSPG2 LAMA5 USH2A	2.44e-03	44	114	3	SM00282
Domain	Growth_fac_rcpt_	HSPG2 LAMA5 FBLN2 TNN LRP2	2.70e-03	156	114	5	IPR009030
Domain	RRM_dom	RBMXL3 RBM45 CSTF2 RBM8A CSTF2T ENOX2	2.70e-03	227	114	6	IPR000504
Domain	RRM	RBMXL3 RBM45 CSTF2 RBM8A CSTF2T ENOX2	2.89e-03	230	114	6	PS50102
Domain	UBA	RNF31 SNRK SIK3	2.95e-03	47	114	3	PS50030
Domain	ZINC_PROTEASE	MMP28 ADAMTS5 ADAM10 ADAMTS15	3.06e-03	98	114	4	PS00142
Domain	DnaJ	DNAJB3 DNAJB5 DNAJB2	3.14e-03	48	114	3	PF00226
Domain	Dynein_heavy_chain_D4_dom	DNAH1 DNAH5	3.20e-03	14	114	2	IPR024317
Domain	Dynein_HC_stalk	DNAH1 DNAH5	3.20e-03	14	114	2	IPR024743
Domain	Dynein_heavy_dom-2	DNAH1 DNAH5	3.20e-03	14	114	2	IPR013602
Domain	DHC_N2	DNAH1 DNAH5	3.20e-03	14	114	2	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH1 DNAH5	3.20e-03	14	114	2	IPR011704
Domain	MT	DNAH1 DNAH5	3.20e-03	14	114	2	PF12777
Domain	AAA_8	DNAH1 DNAH5	3.20e-03	14	114	2	PF12780
Domain	AAA_5	DNAH1 DNAH5	3.20e-03	14	114	2	PF07728
Domain	DNAJ_1	DNAJB3 DNAJB5 DNAJB2	3.33e-03	49	114	3	PS00636
Domain	DNAJ_2	DNAJB3 DNAJB5 DNAJB2	3.33e-03	49	114	3	PS50076
Domain	DnaJ	DNAJB3 DNAJB5 DNAJB2	3.33e-03	49	114	3	SM00271
Domain	-	DNAJB3 DNAJB5 DNAJB2	3.33e-03	49	114	3	1.10.287.110
Domain	DHC_fam	DNAH1 DNAH5	3.68e-03	15	114	2	IPR026983
Domain	Dynein_heavy	DNAH1 DNAH5	3.68e-03	15	114	2	PF03028
Domain	Dynein_heavy_dom	DNAH1 DNAH5	3.68e-03	15	114	2	IPR004273
Domain	DnaJ_domain	DNAJB3 DNAJB5 DNAJB2	3.73e-03	51	114	3	IPR001623
Domain	-	RBMXL3 RBM45 CSTF2 RBM8A CSTF2T ENOX2	3.86e-03	244	114	6	3.30.70.330
Domain	Laminin_N	LAMA5 USH2A	4.19e-03	16	114	2	IPR008211
Domain	LamNT	LAMA5 USH2A	4.19e-03	16	114	2	SM00136
Domain	LAMININ_NTER	LAMA5 USH2A	4.19e-03	16	114	2	PS51117
Domain	Laminin_N	LAMA5 USH2A	4.19e-03	16	114	2	PF00055
Domain	Aminotran_1_2	SPTLC3 SPTLC2	4.73e-03	17	114	2	PF00155
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	HSPG2 FLNA RPL27A HLA-A SPP1 SPTLC2 MXRA8 HLA-G LAMA5 ADAMTS5 SIK3 ADAM10 BCS1L MECP2 GFPT1 GGCX LIG1 FBLN2 CS KARS1 GLCE GFPT2	4.77e-09	1451	120	22	30550785
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	RPL27A B4GAT1 HLA-A MYO1E VPS39 CLIC6 GFPT1 RYR3 MADD CS LMO2 SBNO1 SERGEF LRP2 GFPT2 EIF2AK1 DNAJB2 ALDH5A1 PINK1 DNMT1	1.70e-08	1285	120	20	35914814
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	CUL1 FLNA RBMXL3 MYO1E RBM45 RCC1 CHD3 CHD1L MECP2 GFPT1 GGCX KARS1 SMARCA1 BOP1 RBM8A KLHL12 DBR1 GCN1 DNMT1 HDAC2	4.93e-08	1371	120	20	36244648
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	CUL1 FLNA RPL27A TENT4B HLA-A RBBP5 RCC1 GFPT1 DAP3 CS KARS1 SBNO1 H4C1 SMARCA1 BOP1 DNAH5 GCN1 DNMT1 CKMT1A	4.39e-07	1425	120	19	30948266
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	CUL1 RBBP5 RCC1 CHD3 CHD1L GFPT1 KARS1 SBNO1 H4C1 CNDP2 CSTF2 BOP1 RBM8A CSTF2T DNMT1 HDAC2	4.42e-07	1014	120	16	32416067
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	CUL1 FLNA HLA-A TENT4A RBBP5 RCC1 CHD3 GFPT1 SBNO1 GFPT2 DBR1 GCN1 DNMT1	4.46e-07	653	120	13	33742100
Pubmed	DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci.	MECP2 DNMT1 HDAC2	7.95e-07	6	120	3	10888872
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	HSPG2 ARHGAP32 RNF31 SPP1 TEP1 FBLN2 LRP2 CSTF2 PLEKHA5 KLHL12 CSTF2T KLHL26	1.39e-06	608	120	12	16713569
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	CUL1 FLNA RPL27A RNF31 SPTLC2 RCC1 CHD1L GFPT1 CS KARS1 H4C1 SMARCA1 PLEKHA5 BOP1 RBM8A GCN1 DNMT1	4.18e-06	1353	120	17	29467282
Pubmed	Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing.	MECP2 DNMT1 HDAC2	4.72e-06	10	120	3	15696166
Pubmed	Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition.	CUL1 MAP3K6 CDK10 MAP3K5 PDIK1L EIF2AK1 MAP4K2 PINK1 KLHL26	6.13e-06	372	120	9	22939624
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	FLNA RPL27A HLA-A MYO1E RBBP5 RCC1 GFPT1 KARS1 H4C1 BOP1 GCN1 DNMT1	6.85e-06	711	120	12	33022573
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	FLNA RPL27A TENT4B MYO1E DDX60 MECP2 GFPT1 DAP3 MYOF KARS1 H4C1 SMARCA1 PLEKHA5 BOP1 RBM8A DNMT1	7.01e-06	1257	120	16	36526897
Pubmed	Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.	FLNA RPL27A HLA-A RCC1 CHD3 DNAJB3 MADD DAP3 CS RBM8A GCN1 CKMT1A	7.15e-06	714	120	12	28302793
Pubmed	FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.	HSPG2 FLNA RPL27A MYO1E GFPT1 DAP3 KARS1 H4C1 SMARCA1 GCN1 DNMT1	7.95e-06	601	120	11	33658012
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	RBBP5 CHD3 CHD1L MECP2 ARID3B DAP3 SBNO1 SMARCA1 BOP1 DNMT1 HDAC2	8.85e-06	608	120	11	36089195
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	CUL1 TENT4B TENT4A SIK3 CDK10 GFPT1 ADAMTS15 LRP2 KLHL12 GFPT2 DNAH5 HDAC2	8.92e-06	730	120	12	34857952
Pubmed	Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.	HSPG2 FLNA LAMA5 RCC1 TEP1 BCS1L DNAH5	1.00e-05	214	120	7	22199357
Pubmed	cDNA cloning and mapping of a novel subtype of glutamine:fructose-6-phosphate amidotransferase (GFAT2) in human and mouse.	SNRK GFPT1 GFPT2	1.12e-05	13	120	3	10198162
Pubmed	Mesangial cells organize the glomerular capillaries by adhering to the G domain of laminin alpha5 in the glomerular basement membrane.	HSPG2 LAMA5 FBLN2	1.12e-05	13	120	3	12682087
Pubmed	A family of splice variants of CstF-64 expressed in vertebrate nervous systems.	CSTF2 CSTF2T	1.18e-05	2	120	2	19284619
Pubmed	Expression of Dnmt1, demethylase, MeCP2 and methylation of tumor-related genes in human gastric cancer.	MECP2 DNMT1	1.18e-05	2	120	2	15526354
Pubmed	Recognition of GU-rich polyadenylation regulatory elements by human CstF-64 protein.	CSTF2 CSTF2T	1.18e-05	2	120	2	12773396
Pubmed	DNMT1 and HDAC2 Cooperate to Facilitate Aberrant Promoter Methylation in Inorganic Phosphate-Induced Endothelial-Mesenchymal Transition.	DNMT1 HDAC2	1.18e-05	2	120	2	26815200
Pubmed	Polyadenylation proteins CstF-64 and tauCstF-64 exhibit differential binding affinities for RNA polymers.	CSTF2 CSTF2T	1.18e-05	2	120	2	17029590
Pubmed	The topoisomerase-related function gene TRF4 affects cellular sensitivity to the antitumor agent camptothecin.	TENT4B TENT4A	1.18e-05	2	120	2	10066793
Pubmed	Chemical inhibition of PAPD5/7 rescues telomerase function and hematopoiesis in dyskeratosis congenita.	TENT4B TENT4A	1.18e-05	2	120	2	32559291
Pubmed	Overlapping and distinct functions of CstF64 and CstF64τ in mammalian mRNA 3' processing.	CSTF2 CSTF2T	1.18e-05	2	120	2	24149845
Pubmed	Reduced recognition memory is correlated with decrease in DNA methyltransferase1 and increase in histone deacetylase2 protein expression in old male mice.	DNMT1 HDAC2	1.18e-05	2	120	2	24924148
Pubmed	Mixed tailing by TENT4A and TENT4B shields mRNA from rapid deadenylation.	TENT4B TENT4A	1.18e-05	2	120	2	30026317
Pubmed	Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma.	SPP1 DNMT1	1.18e-05	2	120	2	30064482
Pubmed	Cloning and partial characterization of the mouse glutamine:fructose-6-phosphate amidotransferase (GFAT) gene promoter.	GFPT1 GFPT2	1.18e-05	2	120	2	9060444
Pubmed	Developmental distribution of the polyadenylation protein CstF-64 and the variant tauCstF-64 in mouse and rat testis.	CSTF2 CSTF2T	1.18e-05	2	120	2	14681198
Pubmed	ASK1 and ASK2 differentially regulate the counteracting roles of apoptosis and inflammation in tumorigenesis.	MAP3K6 MAP3K5	1.18e-05	2	120	2	19214184
Pubmed	Cardiomyocyte protein O-GlcNAcylation is regulated by GFAT1 not GFAT2.	GFPT1 GFPT2	1.18e-05	2	120	2	34735873
Pubmed	Mutations in the SPTLC2 subunit of serine palmitoyltransferase cause hereditary sensory and autonomic neuropathy type I.	SPTLC3 SPTLC2	1.18e-05	2	120	2	20920666
Pubmed	Hippocampal chromatin-modifying enzymes are pivotal for scopolamine-induced synaptic plasticity gene expression changes and memory impairment.	DNMT1 HDAC2	1.18e-05	2	120	2	25982413
Pubmed	Elevated levels of the 64-kDa cleavage stimulatory factor (CstF-64) in lipopolysaccharide-stimulated macrophages influence gene expression and induce alternative poly(A) site selection.	CSTF2 CSTF2T	1.18e-05	2	120	2	16207706
Pubmed	HLA-G*0105N and HLA-G 14 bp dimorphisms in exon 8 in four distinct populations in mainland China.	HLA-A HLA-G	1.18e-05	2	120	2	20030786
Pubmed	Apoptosis signal-regulating kinase (ASK) 2 functions as a mitogen-activated protein kinase kinase kinase in a heteromeric complex with ASK1.	MAP3K6 MAP3K5	1.18e-05	2	120	2	17210579
Pubmed	MAPKKK6, a novel mitogen-activated protein kinase kinase kinase, that associates with MAPKKK5.	MAP3K6 MAP3K5	1.18e-05	2	120	2	9875215
Pubmed	Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.	B4GAT1 MYO1E VPS39 SPTLC2 SIK3 GGCX DAP3 SBNO1 PLEKHA5 GCN1 DNMT1 HDAC2	1.23e-05	754	120	12	33060197
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	RNF31 MYO1E TENT4A VPS39 LAMA5 KLHL12 GCN1 HDAC2	1.38e-05	313	120	8	38270169
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	RNF31 ERCC6L RBBP5 CHD3 SIK3 MAP3K6 MADD PHKA2 PLEKHA5 DBR1 DNMT1	1.65e-05	650	120	11	38777146
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	CUL1 HLA-A GRIA2 RCC1 SIK3 MAP3K6 CDK10 PHKA2 MYOF NRK BOP1 RBM8A HDAC2	1.65e-05	910	120	13	36736316
Pubmed	Proteomic analysis of SARS-CoV-2 particles unveils a key role of G3BP proteins in viral assembly.	HSPG2 FLNA HLA-A LAMA5 MYOF	1.83e-05	93	120	5	38245532
Pubmed	Isolation of novel tissue-specific genes from cDNA libraries representing the individual tissue constituents of the gastrulating mouse embryo.	RNF31 CLIC6 LIG1 BMPR2 KARS1 SBNO1 CSTF2 RBM8A GCN1	2.01e-05	432	120	9	7671812
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	FLNA SPP1 RBBP5 RCC1 CHD3 MYOF DNAH5 DNMT1	2.11e-05	332	120	8	37433992
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	FLNA ERCC6L RCC1 ARID3B CSTF2 PLEKHA5 GCN1 CSTF2T DNMT1 HDAC2	2.18e-05	549	120	10	38280479
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	FLNA RPL27A TENT4B RBM45 DAP3 CS H4C1 CSTF2 RBM8A GCN1 CSTF2T HDAC2	2.40e-05	807	120	12	22681889
Pubmed	Analysis of mammalian proteins involved in chromatin modification reveals new metaphase centromeric proteins and distinct chromosomal distribution patterns.	MECP2 DNMT1 HDAC2	2.63e-05	17	120	3	14519686
Pubmed	The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA.	HSPG2 TENT4B MECP2 H4C1 SMARCA1 BOP1 DNMT1 HDAC2	3.01e-05	349	120	8	25665578
Pubmed	GFPT2/GFAT2 and AMDHD2 act in tandem to control the hexosamine pathway.	GFPT1 GFPT2	3.53e-05	3	120	2	35229715
Pubmed	The C-terminal domain V of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans.	HSPG2 FBLN2	3.53e-05	3	120	2	9431988
Pubmed	Is the mammalian serine palmitoyltransferase a high-molecular-mass complex?	SPTLC3 SPTLC2	3.53e-05	3	120	2	17331073
Pubmed	The ASK family kinases differentially mediate induction of type I interferon and apoptosis during the antiviral response.	MAP3K6 MAP3K5	3.53e-05	3	120	2	26243192
Pubmed	Fibulin-2 binds to the short arms of laminin-5 and laminin-1 via conserved amino acid sequences.	LAMA5 FBLN2	3.53e-05	3	120	2	9006922
Pubmed	The genomic and clinical landscape of fetal akinesia.	RYR3 GCN1	3.53e-05	3	120	2	31680123
Pubmed	Air1 zinc knuckles 4 and 5 and a conserved IWRXY motif are critical for the function and integrity of the Trf4/5-Air1/2-Mtr4 polyadenylation (TRAMP) RNA quality control complex.	TENT4B TENT4A	3.53e-05	3	120	2	21878619
Pubmed	Viral hijacking of the TENT4-ZCCHC14 complex protects viral RNAs via mixed tailing.	TENT4B TENT4A	3.53e-05	3	120	2	32451488
Pubmed	The ZCCHC14/TENT4 complex is required for hepatitis A virus RNA synthesis.	TENT4B TENT4A	3.53e-05	3	120	2	35867748
Pubmed	Holocarboxylase synthetase synergizes with methyl CpG binding protein 2 and DNA methyltransferase 1 in the transcriptional repression of long-terminal repeats.	MECP2 DNMT1	3.53e-05	3	120	2	23624957
Pubmed	Cleavage of Fibulin-2 by the aggrecanases ADAMTS-4 and ADAMTS-5 contributes to the tumorigenic potential of breast cancer cells.	ADAMTS5 FBLN2	3.53e-05	3	120	2	28099917
Pubmed	MeCP2 and histone deacetylases 1 and 2 in dorsal striatum collectively suppress repetitive behaviors.	MECP2 HDAC2	3.53e-05	3	120	2	27668390
Pubmed	Structure-based mechanism of preferential complex formation by apoptosis signal-regulating kinases.	MAP3K6 MAP3K5	3.53e-05	3	120	2	32156783
Pubmed	The expression patterns and correlations of claudin-6, methy-CpG binding protein 2, DNA methyltransferase 1, histone deacetylase 1, acetyl-histone H3 and acetyl-histone H4 and their clinicopathological significance in breast invasive ductal carcinomas.	MECP2 DNMT1	3.53e-05	3	120	2	22455563
Pubmed	ASK family kinases mediate cellular stress and redox signaling to circadian clock.	MAP3K6 MAP3K5	3.53e-05	3	120	2	29555767
Pubmed	ASK1/2 signaling promotes inflammation in a mouse model of neutrophilic dermatosis.	MAP3K6 MAP3K5	3.53e-05	3	120	2	29629899
Pubmed	The clinical variability of the MECP2 duplication syndrome: description of two families with duplications excluding L1CAM and FLNA.	FLNA MECP2	3.53e-05	3	120	2	19018795
Pubmed	Selective impact of MeCP2 and associated histone deacetylases on the dynamics of evoked excitatory neurotransmission.	MECP2 HDAC2	3.53e-05	3	120	2	21511710
Pubmed	Human bone marrow mesenchymal stem cell-derived extracellular vesicles reduce inflammation and pyroptosis in acute kidney injury via miR-223-3p/HDAC2/SNRK.	SNRK HDAC2	3.53e-05	3	120	2	36640195
Pubmed	Epigenetic modification of intestinal smooth muscle cell phenotype during proliferation.	DNMT1 HDAC2	3.53e-05	3	120	2	30110565
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	FLNA CHD1L NPEPL1 KARS1 CNDP2 PLEKHA5 DBR1 MAP4K2	3.74e-05	360	120	8	33111431
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	SPP1 RCC1 CHD3 MECP2 ARID3B LIG1 SMARCA1 GCN1 DNMT1	3.81e-05	469	120	9	27634302
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	CFAP251 MYO1E IP6K1 CHD1L GGCX SBK1 PLEKHA5 DBR1	3.82e-05	361	120	8	26167880
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	HSPG2 FLNA ARHGAP32 LAMA5 GFPT1 MYOF CNDP2 ALPG	3.97e-05	363	120	8	14691545
Pubmed	ETO2 coordinates cellular proliferation and differentiation during erythropoiesis.	RCC1 LMO2 HDAC2	4.37e-05	20	120	3	16407974
Pubmed	SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB.	RCC1 BCS1L GFPT1 DAP3 MYOF CS KARS1 CSTF2 GCN1 CKMT1A	5.07e-05	607	120	10	39147351
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	CUL1 HSPG2 B4GAT1 LAMA5 ADAM10 GGCX KARS1 H4C1 TTC13 GCN1	5.50e-05	613	120	10	22268729
Pubmed	Histone-binding of DPF2 mediates its repressive role in myeloid differentiation.	RBBP5 GFPT1 H4C1 CSTF2 CSTF2T DNMT1 HDAC2	5.96e-05	283	120	7	28533407
Pubmed	Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins.	B4GAT1 SPTLC2 MXRA8 ADAM10 GGCX MYOF LMO2 DNAJB5 GCN1	6.14e-05	499	120	9	22810586
Pubmed	Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.	RBMXL3 VPS39 DDX60 CHD3 TTC13 DNAJB5 GCN1	6.23e-05	285	120	7	32838362
Pubmed	β-TrCP-dependent degradation of ASK1 suppresses the induction of the apoptotic response by oxidative stress.	MAP3K6 MAP3K5	7.05e-05	4	120	2	30031111
Pubmed	Soluble HLA class I molecules induce natural killer cell apoptosis through the engagement of CD8: evidence for a negative regulation exerted by members of the inhibitory receptor superfamily.	HLA-A HLA-G	7.05e-05	4	120	2	11861287
Pubmed	Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1.	MECP2 DNMT1	7.05e-05	4	120	2	12473678
Pubmed	Cigarette smoke induces proteasomal-mediated degradation of DNA methyltransferases and methyl CpG-/CpG domain-binding proteins in embryonic orofacial cells.	MECP2 DNMT1	7.05e-05	4	120	2	26482727
Pubmed	Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation.	MECP2 DNMT1	7.05e-05	4	120	2	19109157
Pubmed	The gene for a variant form of the polyadenylation protein CstF-64 is on chromosome 19 and is expressed in pachytene spermatocytes in mice.	CSTF2 CSTF2T	7.05e-05	4	120	2	11113135
Pubmed	Mutations in dynein genes in patients affected by isolated non-syndromic asthenozoospermia.	DNAH1 DNAH5	7.05e-05	4	120	2	18492703
Pubmed	Dual engagement of 14-3-3 proteins controls signal relay from ASK2 to the ASK1 signalosome.	MAP3K6 MAP3K5	7.05e-05	4	120	2	19935702
Pubmed	Repression of 92-kDa type IV collagenase expression by MTA1 is mediated through direct interactions with the promoter via a mechanism, which is both dependent on and independent of histone deacetylation.	CHD3 HDAC2	7.05e-05	4	120	2	12431981
Pubmed	Soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis.	HLA-A HLA-G	7.05e-05	4	120	2	18782112
Pubmed	The collagen type XVIII endostatin domain is co-localized with perlecan in basement membranes in vivo.	HSPG2 FBLN2	7.05e-05	4	120	2	12588956
Pubmed	Lys29-linkage of ASK1 by Skp1-Cullin 1-Fbxo21 ubiquitin ligase complex is required for antiviral innate response.	CUL1 MAP3K5	7.05e-05	4	120	2	27063938
Pubmed	Mutations in gfpt1 and skiv2l2 cause distinct stage-specific defects in larval melanocyte regeneration in zebrafish.	GFPT1 GFPT2	7.05e-05	4	120	2	17542649
Pubmed	Daxx and histone deacetylase II associate with chromatin through an interaction with core histones and the chromatin-associated protein Dek.	H4C1 HDAC2	7.05e-05	4	120	2	12140263
Pubmed	Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution.	HLA-A HLA-G	7.05e-05	4	120	2	19762282
Pubmed	Unchanged PCNA and DNMT1 dynamics during replication in DNA ligase I-deficient cells but abnormal chromatin levels of non-replicative histone H1.	LIG1 DNMT1	7.05e-05	4	120	2	36928068
Pubmed	Biosynthesis and expression of a disintegrin-like and metalloproteinase domain with thrombospondin-1 repeats-15: a novel versican-cleaving proteoglycanase.	ADAMTS5 ADAMTS15	7.05e-05	4	120	2	24220035
Pubmed	Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation.	MECP2 DNMT1	7.05e-05	4	120	2	17296936
Interaction	RPS25 interactions	CUL1 RPL27A RNF31 RBM45 RBBP5 STAC3 CHD3 MECP2 H4C1 RBM8A DNAJB5 HDAC2	3.62e-06	392	119	12	int:RPS25
Interaction	CPSF2 interactions	RNF31 RBBP5 CHD3 MECP2 H4C1 CSTF2 CSTF2T HDAC2	8.75e-06	173	119	8	int:CPSF2
Interaction	PYHIN1 interactions	HSPG2 RBBP5 LAMA5 MECP2 DAP3 H4C1 SMARCA1 BOP1 PADI3 DNMT1 HDAC2	9.08e-06	358	119	11	int:PYHIN1
Interaction	H2BC9 interactions	ERCC6L MMP28 CHD3 TEP1 DNAH1 KARS1 SBNO1 H4C1 TNN DNAH5 PINK1 DNMT1	1.33e-05	446	119	12	int:H2BC9
Interaction	PABPN1 interactions	CUL1 RNF31 RBM45 MECP2 H4C1 RBM8A COA7 PINK1	1.87e-05	192	119	8	int:PABPN1
Interaction	RBM14 interactions	CUL1 RNF31 RBM45 RCC1 CHD3 MECP2 H4C1 CSTF2 RBM8A EIF2AK1 CSTF2T PINK1 HDAC2	2.38e-05	553	119	13	int:RBM14
Interaction	CLIC6 interactions	MYO1E CLIC6 GFPT2 ALDH5A1	2.45e-05	29	119	4	int:CLIC6
Interaction	VBP1 interactions	FLNA ARHGAP32 RNF31 MSH4 KARS1 LMO2 HDAC2 KLHL26	2.78e-05	203	119	8	int:VBP1
Interaction	CFD interactions	HSPG2 FLNA RPL27A SPP1 SPTLC2 MXRA8 LAMA5 ADAMTS5 SIK3 ADAM10 BCS1L MECP2 GFPT1 GGCX LIG1 FBLN2 CS KARS1 H4C1 GLCE GFPT2	4.36e-05	1360	119	21	int:CFD
Interaction	MTDH interactions	HSPG2 FLNA LAMA5 GRIA2 RCC1 CHD3 TEP1 BCS1L MECP2 H4C1 RBM8A DNAH5	4.50e-05	505	119	12	int:MTDH
Interaction	PABPC1 interactions	CUL1 FLNA RPL27A RNF31 RBM45 CHD3 ADAM10 KARS1 H4C1 CNDP2 CSTF2 RBM8A PINK1 HDAC2	6.56e-05	699	119	14	int:PABPC1
Interaction	RPL13 interactions	CUL1 RPL27A TENT4B RNF31 RBM45 SPP1 CHD3 MECP2 DAP3 H4C1 BOP1 RBM8A PINK1 HDAC2	6.66e-05	700	119	14	int:RPL13
Cytoband	Ensembl 112 genes in cytogenetic band chr1p36	HSPG2 MXRA8 PEX10 MAP3K6 LACTBL1 PDIK1L PLCH2 PADI3 PINK1	8.00e-05	681	120	9	chr1p36
Cytoband	12p12	GUCY2C PLEKHA5	5.19e-04	13	120	2	12p12
GeneFamily	Non-canonical poly(A) polymerases	TENT4B TENT4A	4.84e-04	7	88	2	1318
GeneFamily	RNA binding motif containing	RBMXL3 RBM45 CSTF2 RBM8A CSTF2T ENOX2	6.05e-04	213	88	6	725
GeneFamily	PHD finger proteins\|NuRD complex	CHD3 HDAC2	1.50e-03	12	88	2	1305
GeneFamily	DNAJ (HSP40) heat shock proteins\|C2 tensin-type domain containing	DNAJB3 DNAJB5 DNAJB2	1.75e-03	49	88	3	584
Coexpression	GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_UP	MYO1E TENT4A SPP1 SLC25A26 ADAM10 BMPR2 COA7 MYBPC2	3.90e-06	199	120	8	M7845
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HSPG2 CILP STAC3 ADAMTS5 FBLN2 PCDH19 GFPT2	5.93e-07	180	120	7	39ae8586efd91536e9ac6408d26de7e6d6237c41
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_D\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	ARHGAP32 RNF31 RBM45 MXRA8 LAMA5 LMO2	3.07e-06	148	120	6	10dcbdb47cac908648d9d652c8095b536db19b8a
ToppCell	droplet-Pancreas-Exocrine-18m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 FLNA SPP1 MYOF FBLN2 ADAMTS15	6.59e-06	169	120	6	53690d6f9712b54aa99a0408aae930d64ae478e5
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_D\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ARHGAP32 RNF31 LAMA5 FBLN2 LMO2 PLCH2	7.05e-06	171	120	6	943fbca8a6ac04052a2a85aca7b21a3461cd96f7
ToppCell	Substantia_nigra-Macroglia-OLIGODENDROCYTE-O2-Tnr-Oligodendrocyte.Tnr.Rps24_(Rps24)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	ERCC6L MSH4 LCT USH2A MYBPC2	8.01e-06	101	120	5	c075aa59acf333b05b6533b8172dc0c5c31b6ed3
ToppCell	Substantia_nigra-Macroglia-OLIGODENDROCYTE-O2-Tnr-Oligodendrocyte.Tnr.Rps24_(Rps24)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	ERCC6L MSH4 LCT USH2A MYBPC2	8.01e-06	101	120	5	be1c3034c2ebe64b7dd7a9b31ea43336ea1eeb73
ToppCell	Substantia_nigra-Macroglia-OLIGODENDROCYTE-O2-Tnr\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	ERCC6L MSH4 LCT USH2A MYBPC2	8.01e-06	101	120	5	8ce6ebda05081dbd7db891e5da8af9cc7d4beacb
ToppCell	droplet-Limb_Muscle-nan-18m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 FLNA RPL27A CILP SPP1 CNDP2	9.44e-06	180	120	6	d3d0be136fff5d3e39ecf5a5dbefc1d0d0a6c814
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RYR3 DNAH1 NRK LRP2 DNAH5 USH2A	1.07e-05	184	120	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RYR3 DNAH1 NRK LRP2 DNAH5 USH2A	1.07e-05	184	120	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RYR3 DNAH1 NRK LRP2 DNAH5 USH2A	1.07e-05	184	120	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	metastatic_Lymph_Node-Fibroblasts-COL14A1+_matrix_FBs\|metastatic_Lymph_Node / Location, Cell class and cell subclass	HSPG2 CILP MXRA8 ADAMTS5 FBLN2 GFPT2	1.10e-05	185	120	6	506eee2c1b6e8acec3aa8b2c66868010006c4c14
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HSPG2 CILP ADAMTS5 FBLN2 PLCH2 GFPT2	1.14e-05	186	120	6	7c1807fca590cdccf7f5734460bac228d33964ca
ToppCell	facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CILP MXRA8 ADAMTS5 FBLN2 CNDP2 GFPT2	1.14e-05	186	120	6	a7ab70b049742dfe7ee30557031bfac6412edf52
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MPP2 CILP MXRA8 ADAMTS5 FBLN2 GFPT2	1.21e-05	188	120	6	e18065bbc26d6f3774fd1f478fb41d8fb555fa26
ToppCell	human_hepatoblastoma-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	MYO1E MAP3K5 MYOF FBLN2 LMO2 FGF9	1.21e-05	188	120	6	b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCell	LV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	MXRA8 ADAMTS5 FBLN2 NRK PLEKHA5 GFPT2	1.32e-05	191	120	6	d36565257ccba8c1bbed2c1c01be66a9cbb5f834
ToppCell	PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPTLC3 CFAP251 CLIC6 DNAH1 TNN DNAH5	1.32e-05	191	120	6	96483adb97c81208aa513782550acd8a08b63866
ToppCell	droplet-Kidney-KIDNEY-30m-Mesenchymal-fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CILP MXRA8 ADAMTS5 FBLN2 PCDH19 GFPT2	1.36e-05	192	120	6	853a930e0641ffb50cbb4cef5837c70d75c3fc39
ToppCell	facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 CILP MXRA8 ADAMTS5 FBLN2 GFPT2	1.36e-05	192	120	6	671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5
ToppCell	facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 MXRA8 ADAMTS5 FBLN2 ADAMTS15 GFPT2	1.36e-05	192	120	6	8937a59f6bbe07f671bdabbd3707dc9c17a14cd9
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CILP MXRA8 ADAMTS5 FBLN2 PLEKHA5 GFPT2	1.36e-05	192	120	6	11088878043a6ff95ba1970361256a82e434b80a
ToppCell	facs-Pancreas-Exocrine-3m-Mesenchymal\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 MXRA8 ADAMTS5 FBLN2 ADAMTS15 GFPT2	1.36e-05	192	120	6	e4a7f2673f801b008ca67291db2fb2b9fd2955b8
ToppCell	facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 MXRA8 ADAMTS5 FBLN2 ADAMTS15 GFPT2	1.36e-05	192	120	6	ac1477433704573f95111eee6263b93668d2845e
ToppCell	facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 CILP MXRA8 ADAMTS5 FBLN2 GFPT2	1.36e-05	192	120	6	840a34c1b82d218be999ab5e1bcafd6370d7a4b1
ToppCell	droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HSPG2 CILP MXRA8 ADAMTS5 FBLN2 GFPT2	1.36e-05	192	120	6	f9fb24457999dc9e751a099d7f995543b9330ad4
ToppCell	droplet-Kidney-KIDNEY-30m-Mesenchymal\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CILP MXRA8 ADAMTS5 FBLN2 PCDH19 GFPT2	1.36e-05	192	120	6	49281626ecad0456fdbded2378b7028d7b589686
ToppCell	droplet-Limb_Muscle-nan-18m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 RPL27A ADAMTS5 FBLN2 CNDP2 GFPT2	1.36e-05	192	120	6	2d9e2262f1342fe17735f21f733c029d1275e955
ToppCell	droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HSPG2 CILP MXRA8 ADAMTS5 FBLN2 GFPT2	1.40e-05	193	120	6	9d0b966d13cbce97beb43de6dc77f006c363a181
ToppCell	droplet-Limb_Muscle-nan-18m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 RPL27A CILP MXRA8 ADAMTS5 GFPT2	1.40e-05	193	120	6	49600db68ed65cafc67bd45a285b364e4f5f88af
ToppCell	droplet-Limb_Muscle-nan-3m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 CILP MXRA8 ADAMTS5 FBLN2 GFPT2	1.40e-05	193	120	6	428b1a3ad87dff7f65de5161d40f102572a9341b
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HSPG2 CILP MXRA8 ADAMTS5 FBLN2 GFPT2	1.40e-05	193	120	6	e27885a9e1a2a3e165c5366d4cfcda05c5454483
ToppCell	droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 CILP MXRA8 ADAMTS5 FBLN2 GFPT2	1.40e-05	193	120	6	45b5cab4dfeb0ed3b13631db5963740a792b810f
ToppCell	wk_08-11-Endothelial-Blood_vessel_endothelial-intermediate_cap\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	HSPG2 HLA-A MMP28 SNRK LMO2 MAP4K2	1.49e-05	195	120	6	c0ea25ed1a849e6efff885e98013a4f1d5134758
ToppCell	IPF-Stromal-Fibroblast\|World / Disease state, Lineage and Cell class	SH3TC2 CILP MXRA8 ADAMTS5 FBLN2 GFPT2	1.49e-05	195	120	6	9c32756edb54f0c211185d9a98073fe01fd1526a
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HSPG2 SPTLC2 MMP28 SNRK LMO2 MAP4K2	1.49e-05	195	120	6	9ad4981c4d157edc752de206ab0d754aa14beab8
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_9\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CUL1 MYO1E SPTLC2 STAC3 FBLN2 LMO2	1.49e-05	195	120	6	dd28c63b53f2a97e3fac127294a465870dc371b3
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_9\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CUL1 MYO1E SPTLC2 STAC3 FBLN2 LMO2	1.49e-05	195	120	6	d6ff38535898f90be6719cd5152291f2f4f8a746
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-innate_lymphocytic\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HSPG2 RPL27A HLA-A CILP MXRA8 FBLN2	1.53e-05	196	120	6	6a91b28fc380fa21ea1832d9fa8c50e505bd0aa0
ToppCell	IPF-Stromal-Fibroblast\|IPF / Disease state, Lineage and Cell class	SH3TC2 CILP MXRA8 ADAMTS5 FBLN2 GFPT2	1.53e-05	196	120	6	f7ae604ba32b322d86d68b2b54892e7c6ab06c49
ToppCell	Control-Stromal-Fibroblast\|Control / Disease state, Lineage and Cell class	SH3TC2 CILP MXRA8 ADAMTS5 FBLN2 GFPT2	1.53e-05	196	120	6	7ca94477498a84cafcdd9933ee92a6cbde76c70e
ToppCell	wk_08-11-Endothelial\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	HSPG2 HLA-A MMP28 SNRK LMO2 MAP4K2	1.53e-05	196	120	6	0e545874083fd8e954a49fc397d57a86b081008b
ToppCell	Control-Stromal-Fibroblast\|World / Disease state, Lineage and Cell class	SH3TC2 CILP MXRA8 ADAMTS5 FBLN2 GFPT2	1.53e-05	196	120	6	1ec7a4daa51b3156db97e1fd6cb925ad311bb4b5
ToppCell	Control-Stromal\|Control / Disease state, Lineage and Cell class	SH3TC2 CILP MXRA8 ADAMTS5 FBLN2 GFPT2	1.62e-05	198	120	6	ae726b6b7f0a4107899be4d32ac256ffa0bd8d59
ToppCell	distal-3-mesenchymal-Adventitial_Fibroblast\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CILP MXRA8 ADAMTS5 FBLN2 FGF9 GFPT2	1.67e-05	199	120	6	547a7c30abc730af2670aee00c7a6af60426c9ac
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SH3TC2 CILP MXRA8 ADAMTS5 FBLN2 GFPT2	1.67e-05	199	120	6	f835e7ffe976843b0edbf695762d463da85793f3
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SH3TC2 CILP MXRA8 ADAMTS5 FBLN2 GFPT2	1.67e-05	199	120	6	993fa050a095017135a6e723c77cd38b9d782e58
ToppCell	distal-mesenchymal-Adventitial_Fibroblast-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CILP MXRA8 ADAMTS5 FBLN2 FGF9 GFPT2	1.67e-05	199	120	6	6e8a44e46b46e87b81dbfc56fcbbcde166fd00fe
ToppCell	(5)_Fibroblast-F\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	MXRA8 ADAMTS5 FBLN2 ADAMTS15 FGF9 GFPT2	1.67e-05	199	120	6	1f66db4f502de4a5159cde90fcb3befb26b8d375
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CILP MXRA8 ADAMTS5 FBLN2 FGF9 GFPT2	1.72e-05	200	120	6	28e5354008adf97b17333f17f8cbef930db6729a
ToppCell	3'-Adult-LargeIntestine-Endothelial-blood_vessel_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HSPG2 LAMA5 SNRK BMPR2 FBLN2 LMO2	1.72e-05	200	120	6	074b5766c61fa8e61d0b1b76688ea0d1ec401e5b
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CILP MXRA8 ADAMTS5 FBLN2 FGF9 GFPT2	1.72e-05	200	120	6	56536236a7012efdb28f85b40e464f3da3e87ce8
ToppCell	distal-mesenchymal-Adventitial_Fibroblast\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CILP MXRA8 ADAMTS5 FBLN2 FGF9 GFPT2	1.72e-05	200	120	6	687cfada2d0977e8985e0a73a5804f84f2ca9c52
ToppCell	E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_B\|E18.5-samps / Age Group, Lineage, Cell class and subclass	MPP2 DNAH1 SBK1 ADAMTS15 PADI3	3.50e-05	137	120	5	b553958e7e6dcd887d860e34d3983cbb85cefaa6
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-10\|TCGA-Colorectal / Sample_Type by Project: Shred V9	CILP ADAMTS5 TNN NRK GFPT2	6.11e-05	154	120	5	511923b27469ea20f8bd82a9ec27119a6e884644
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SPTLC3 SPP1 RYR3 ARSH DNAH5	8.23e-05	164	120	5	1cb5fbd7050650047ad6f2ca792118e98d58d22b
ToppCell	367C-Fibroblasts-Fibroblast-F\|367C / Donor, Lineage, Cell class and subclass (all cells)	GRIA2 ADAMTS5 FBLN2 ADAMTS15 GFPT2	8.71e-05	166	120	5	2887f4f0c218cbcbcc82eef27aa4ee714b35cddb
ToppCell	367C-Fibroblasts-Fibroblast-F-\|367C / Donor, Lineage, Cell class and subclass (all cells)	GRIA2 ADAMTS5 FBLN2 ADAMTS15 GFPT2	8.71e-05	166	120	5	1cc291a04f4144abba4aca7badeb7776db05d903
ToppCell	droplet-Marrow-BM-1m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPP2 MAP3K6 PHKA2 MYOF DNAJB2	9.22e-05	168	120	5	2e88d9cb7c80a4656fab290db8b45a5a0599d769
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RYR3 DNAH1 LRP2 DNAH5 USH2A	9.48e-05	169	120	5	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HSPG2 SIK3 MADD FBLN2 LMO2	9.74e-05	170	120	5	55fe16d98ea284d05fb899888e4569c685644c7b
ToppCell	droplet-Pancreas-Exocrine-18m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNA SPP1 MYOF ADAMTS15 DNAH5	1.00e-04	171	120	5	5447b78148f7bccb727e2fc108589b2af02a5d31
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CILP MXRA8 ADAMTS5 FBLN2 GFPT2	1.03e-04	172	120	5	e37c0b5b547a7345179ab258dd2141fec7064c17
ToppCell	PND07-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MADD ARID3B PHKA2 LIG1 DNMT1	1.06e-04	173	120	5	28c98a9a54aa2cfa67464db4f628c9357ad185b9
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_3\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	HSPG2 MXRA8 ADAMTS5 SMARCA1 GFPT2	1.18e-04	177	120	5	3d955ea938a1d2fb1b6d68d4997fd454bd632dfc
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HSPG2 SH3TC2 SPP1 LMO2 MAP4K2	1.21e-04	178	120	5	60263c0bb9de3a57ba2ba543262a2ace0066fd85
ToppCell	droplet-Limb_Muscle-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPL27A CILP FBLN2 CNDP2 GFPT2	1.24e-04	179	120	5	013818e173101efca7625ccd4258e60655815d73
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADAMTS5 DNAH1 FBLN2 PCDH19 GFPT2	1.27e-04	180	120	5	c4068fe47408cfd899131a85fa4b7e5908926f94
ToppCell	B_cell_maturation-immature_B_cell\|World / Lineage and Cell class	CFAP251 LAMA5 FAM3B GUCY2C MYBPC2	1.34e-04	182	120	5	2c7c51ebc4125d8a33454ffee0b143579ce5e451
ToppCell	5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HSPG2 MMP28 SNRK FBLN2 LMO2	1.34e-04	182	120	5	d0e3663f7d39f22a3ebd7fde56ab3504773598f4
ToppCell	droplet-Pancreas-Exocrine-18m-Endothelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 MAP3K6 FBLN2 LMO2 PCDH19	1.34e-04	182	120	5	3b4dbf61ca0fe50efe05449815630e301cb76630
ToppCell	droplet-Pancreas-Exocrine-18m-Endothelial-endothelial_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 MAP3K6 FBLN2 LMO2 PCDH19	1.34e-04	182	120	5	ab5761bf9af439231cd0f487b6467e372672a517
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CILP MXRA8 ADAMTS5 FBLN2 GFPT2	1.34e-04	182	120	5	d179b5deb07c20d49eb6c58d5a65904f8921de3a
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CILP MXRA8 ADAMTS5 FBLN2 GFPT2	1.38e-04	183	120	5	06a68fa2be36448064f4668be24a5b85ad85c6e8
ToppCell	droplet-Lung-30m-Mesenchymal-myofibroblast\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MPP2 ARHGAP32 MXRA8 PCDH19 SMARCA1	1.41e-04	184	120	5	55dde9c4eebac2a33788c1ff1d8fe312d150fad4
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D122\|Adult / Lineage, Cell type, age group and donor	CILP MXRA8 ADAMTS5 FBLN2 GFPT2	1.41e-04	184	120	5	2b7e6f91e11c228f0521e099886867d9e998e78d
ToppCell	droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell-pericyte\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MPP2 ARHGAP32 MXRA8 PCDH19 SMARCA1	1.41e-04	184	120	5	7128a2be291544d3df3ed6c80f21ddda8437dcba
ToppCell	droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MPP2 ARHGAP32 MXRA8 PCDH19 SMARCA1	1.41e-04	184	120	5	d14238f7b0b55a4c8d7040bea854bd221a66ac30
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HSPG2 CILP FBLN2 PCDH19 GFPT2	1.41e-04	184	120	5	d754c3de621429b220ae4ac426cdfc619e848462
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	B4GAT1 HLA-G RCC1 BCS1L PDIK1L	1.45e-04	185	120	5	ef3c1fd52d21d96f81fb0e5097b24be0ce16e222
ToppCell	390C-Fibroblasts-Fibroblast-F\|390C / Donor, Lineage, Cell class and subclass (all cells)	CILP MXRA8 FBLN2 ADAMTS15 GFPT2	1.45e-04	185	120	5	2c1f14f77faeee2acb388d997c5a27a7fef79be1
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D231\|Adult / Lineage, Cell type, age group and donor	CILP MXRA8 FBLN2 FGF9 GFPT2	1.45e-04	185	120	5	fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804
ToppCell	390C-Fibroblasts-Fibroblast-F-\|390C / Donor, Lineage, Cell class and subclass (all cells)	CILP MXRA8 FBLN2 ADAMTS15 GFPT2	1.45e-04	185	120	5	37db8e0b1f59274227f6fc2362167eb44bd080ef
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Dendritic-plasmacytoid_dendritic_cell\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	B4GAT1 HLA-G RCC1 BCS1L PDIK1L	1.45e-04	185	120	5	c357fa098b561da16c9fa82b0c3563b5cd3fa875
ToppCell	E12.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	LAMA5 FBLN2 ADAMTS15 LRP2 FGF9	1.48e-04	186	120	5	1587667e5084ac43505d027af925ba711e228150
ToppCell	droplet-Mammary_Gland-nan-21m-Mesenchymal-nan\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS5 FBLN2 GUCY2C PCDH19 GFPT2	1.48e-04	186	120	5	cc94e0c5d1665d2ea2bb871ad79d8e1ec2249fb5
ToppCell	facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADAMTS5 BCS1L DNAH1 FBLN2 GFPT2	1.52e-04	187	120	5	fa8f221b4c2df61eadaa9c77e4cf45848b00330b
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO1E MXRA8 ADAMTS5 TNN SMARCA1	1.52e-04	187	120	5	d591a3c216997663ab77710fed0d230ffc37e41a
ToppCell	COVID_non-vent-Myeloid-Dendritic\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	CUL1 MYO1E MYOF FBLN2 LMO2	1.52e-04	187	120	5	936aaca144b79a809617cbe3058bf434a4b3d46a
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO1E MXRA8 ADAMTS5 TNN SMARCA1	1.52e-04	187	120	5	d1dc8c9a2c2cd10c640257161a75e7730ec5bb41
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO1E MXRA8 ADAMTS5 TNN SMARCA1	1.52e-04	187	120	5	ac8e092b37e042975e2ee057d3f7c6821e58e8b5
ToppCell	pdx-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	MYO1E LAMA5 FBLN2 LMO2 FGF9	1.52e-04	187	120	5	7e376831a11ee72ed87abcdac631ca46ae29c250
ToppCell	COVID_non-vent-Myeloid-Dendritic-cDC\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	CUL1 MYO1E MYOF FBLN2 LMO2	1.52e-04	187	120	5	55fe4e8b4f301876716c1af15c34d42164f2358e
ToppCell	Control-Endothelial-VE_Peribronchial\|Endothelial / Disease state, Lineage and Cell class	HSPG2 MYO1E SPP1 MYOF PCDH19	1.52e-04	187	120	5	5429ae85942b8ec3895cceb63c663de3c24ca064
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HSPG2 CILP FBLN2 PCDH19 GFPT2	1.56e-04	188	120	5	6c6486cae9a8f2f8200598cb4bfd3fd513eb28a3
ToppCell	368C-Epithelial_cells-Epithelial-I_(AT1)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	MMP28 LAMA5 TEP1 TTC13 KLHL26	1.56e-04	188	120	5	c74771584b3ba9561a99a54bf55a9203ddf8eff8
ToppCell	droplet-Limb_Muscle-nan-21m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CILP MXRA8 ADAMTS5 FBLN2 GFPT2	1.56e-04	188	120	5	2cfa41c64eccb28b5e22f0f91bbc921b75713245
ToppCell	368C-Epithelial_cells-Epithelial-I_(AT1)\|368C / Donor, Lineage, Cell class and subclass (all cells)	MMP28 LAMA5 TEP1 TTC13 KLHL26	1.56e-04	188	120	5	9155b9a92496e75646778c025b02947e9e9ec73a
ToppCell	droplet-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SPTLC3 CLIC6 DNAH1 TNN DNAH5	1.56e-04	188	120	5	0eca3dc93724e23b71e687fc24fa9f1e89bdef6a
ToppCell	facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HSPG2 CILP ADAMTS5 FBLN2 GFPT2	1.56e-04	188	120	5	bba6b273bd47dd0e27fde914e9e6fc9d76fd5176
Drug	L(-)-vesamicol hydrochloride [112709-59-8]; Down 200; 13.6uM; HL60; HT_HG-U133A	ARHGAP32 B4GAT1 SPTLC2 MECP2 CDK10 GGCX PIK3IP1 GLCE DNAJB5	9.24e-07	196	119	9	3118_DN
Drug	Meropenem [96036-03-2]; Down 200; 10.4uM; MCF7; HT_HG-U133A	MPP2 RNF31 MAP3K6 MECP2 CDK10 LMO2 LRP2 GFPT2 DNAJB2	1.05e-06	199	119	9	3564_DN
Drug	GAMs	GRIA2 GFPT1 KARS1 GFPT2 GRIN3B	1.57e-06	38	119	5	CID000002935
Drug	2-propylpentanoic acid; Up 200; 1000uM; HL60; HT_HG-U133A	B4GAT1 TEP1 PIK3IP1 MYOF PLEKHA5 FGF9 DNAJB5 PINK1	6.68e-06	188	119	8	1150_UP
Drug	Indapamide [26807-65-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A	HSPG2 CHD3 TEP1 MECP2 SERGEF DNAJB5 CSTF2T PADI3	8.41e-06	194	119	8	3859_DN
Drug	Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; HL60; HT_HG-U133A	SPTLC2 CHD3 TEP1 NPEPL1 GGCX GLCE SERGEF MAP4K2	9.76e-06	198	119	8	1320_UP
Drug	Proxyphylline [603-00-9]; Down 200; 16.8uM; HL60; HT_HG-U133A	SPTLC2 CHD3 TEP1 NPEPL1 MECP2 GLCE FGF9 DNAJB5	1.01e-05	199	119	8	3115_DN
Drug	FcDP	GFPT1 GLCE GFPT2	1.14e-05	9	119	3	CID006439892
Drug	sodium oxalate	SPP1 GGCX NRK	1.14e-05	9	119	3	CID000006125
Drug	GYKI 53655	GRIA2 KARS1 CNDP2 GRIN3B	1.75e-05	30	119	4	CID000126757
Drug	aspartate	GRIA2 CLIC6 LCT MAP3K6 GFPT1 CS KARS1 GFPT2 GRIN3B ALDH5A1 CKMT1A MYBPC2	1.77e-05	518	119	12	CID000000424
Drug	4-methylglutamic acid	GRIA2 BCS1L KARS1 GRIN3B	2.00e-05	31	119	4	CID000005365
Drug	Sch 37137	GFPT1 GFPT2	2.71e-05	2	119	2	CID000197244
Drug	Lys-Nva-FMDP	GFPT1 GFPT2	2.71e-05	2	119	2	CID006475796
Drug	FMDP-Val	GFPT1 GFPT2	2.71e-05	2	119	2	CID006475745
Drug	tenocyclidine	SPP1 GFPT1 GRIN3B	2.96e-05	12	119	3	CID000062751
Drug	thapsigargin; Down 200; 0.1uM; PC3; HT_HG-U133A	HSPG2 SH3TC2 B4GAT1 SPTLC2 LAMA5 MAP3K6 SBNO1	4.41e-05	179	119	7	7103_DN
Drug	pentosan polysulfate	HSPG2 SPP1 ADAMTS5 GLCE FGF9	5.93e-05	79	119	5	CID000037720
Drug	L-glutamic acid gamma-monohydroxamate	GFPT1 LIG1 GFPT2 ALDH5A1	6.19e-05	41	119	4	CID000003484
Drug	Oxybutynin chloride [1508-65-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	RNF31 PEX10 RCC1 CDK10 MADD GFPT2 CSTF2T	7.33e-05	194	119	7	3168_DN
Drug	Sulfameter [651-06-9]; Down 200; 14.2uM; PC3; HT_HG-U133A	RNF31 RCC1 NPEPL1 MAP3K6 MECP2 DBR1 ENOX2	7.33e-05	194	119	7	5732_DN
Drug	Corlan	LCT GFPT1 GFPT2	7.42e-05	16	119	3	CID000003643
Drug	5707885; Up 200; 50uM; MCF7; HT_HG-U133A	CHD1L TEP1 PIK3IP1 LRP2 DNAJB5 MAP4K2 CSTF2T	7.57e-05	195	119	7	6433_UP
Drug	Tiletamine hydrochloride; Down 200; 15.4uM; HL60; HT_HG-U133A	SPTLC2 PEX10 MYOF GLCE DNAJB5 ALDH5A1 KLHL26	7.57e-05	195	119	7	3137_DN
Drug	Meclozine dihydrochloride [1104-22-9]; Down 200; 8.6uM; PC3; HT_HG-U133A	ARHGAP32 SPTLC2 DDX60 NPEPL1 CDK10 EIF2AK1 CSTF2T	7.57e-05	195	119	7	4646_DN
Drug	Capsaicin [404-86-4]; Down 200; 13uM; HL60; HT_HG-U133A	HSPG2 NPEPL1 MYOF GLCE ALDH5A1 ENOX2 KLHL26	7.57e-05	195	119	7	3034_DN
Drug	2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A_EA	RNF31 CHD1L MAP3K6 MECP2 PHKA2 EIF2AK1 ENOX2	7.57e-05	195	119	7	989_DN
Drug	adenine	SPP1 BCS1L RYR3 CS GUCY2C EIF2AK1 SLC38A3 DNMT1 CKMT1A MYBPC2 ENOX2	7.64e-05	510	119	11	CID000000190
Drug	Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A	PEX10 RCC1 CHD3 MECP2 CDK10 PHKA2 KLHL26	7.82e-05	196	119	7	3416_DN
Drug	Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; MCF7; HT_HG-U133A	MPP2 CDK10 PIK3IP1 PHKA2 LMO2 DNAJB5 ENOX2	7.82e-05	196	119	7	5279_DN
Drug	Trapidil [15421-84-8]; Down 200; 19.4uM; HL60; HT_HG-U133A	SPTLC3 ARHGAP32 PEX10 PHKA2 LRP2 ALDH5A1 ENOX2	7.82e-05	196	119	7	3136_DN
Drug	Prilocaine hydrochloride [1786-81-8]; Up 200; 15.6uM; HL60; HT_HG-U133A	MPP2 HSPG2 B4GAT1 RCC1 MECP2 BMPR2 LRP2	7.82e-05	196	119	7	2352_UP
Drug	Ethotoin [86-35-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A	SPTLC2 TEP1 MYOF LMO2 DNAJB5 MAP4K2 PINK1	7.82e-05	196	119	7	3892_DN
Drug	Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A	MPP2 RNF31 PIK3IP1 MYOF SERGEF GFPT2 MAP4K2	7.82e-05	196	119	7	5409_DN
Drug	Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A	MYO1E PEX10 RCC1 NPEPL1 MAP3K6 CDK10 PHKA2	7.82e-05	196	119	7	1684_DN
Drug	Methiazole; Down 200; 15uM; PC3; HT_HG-U133A	HSPG2 CHD3 TEP1 NPEPL1 MAP3K6 MECP2 SERGEF	8.07e-05	197	119	7	4532_DN
Drug	Gliquidone [33342-05-1]; Down 200; 7.6uM; HL60; HT_HG-U133A	PEX10 NPEPL1 CDK10 PHKA2 BMPR2 FGF9 DNAJB2	8.07e-05	197	119	7	3126_DN
Drug	Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A	RNF31 RCC1 CHD3 TEP1 MECP2 MADD SERGEF	8.07e-05	197	119	7	4730_DN
Drug	Morantel tartrate [26155-31-7]; Down 200; 10.8uM; PC3; HT_HG-U133A	MYO1E RCC1 CHD3 CDK10 LIG1 BMPR2 EIF2AK1	8.07e-05	197	119	7	1798_DN
Drug	Demecarium bromide [56-94-0]; Down 200; 5.6uM; MCF7; HT_HG-U133A	MPP2 SPTLC2 MECP2 GFPT2 DNAJB5 DNAJB2 ENOX2	8.07e-05	197	119	7	2773_DN
Drug	Minoxidil [38304-91-5]; Up 200; 19.2uM; MCF7; HT_HG-U133A	CHD1L ADAM10 SERGEF LRP2 EIF2AK1 MAP4K2 CSTF2T	8.07e-05	197	119	7	4800_UP
Drug	3-amino-3-deoxy-D-glucose	GFPT1 GFPT2	8.10e-05	3	119	2	CID000164683
Drug	5 PA	GFPT1 GFPT2	8.10e-05	3	119	2	CID000004324
Drug	kanosamine-6-phosphate	GFPT1 GFPT2	8.10e-05	3	119	2	CID000443710
Drug	Avl-FMDP	GFPT1 GFPT2	8.10e-05	3	119	2	CID006473933
Drug	Noscapine [128-62-1]; Down 200; 9.6uM; MCF7; HT_HG-U133A	ARHGAP32 SPTLC2 PEX10 CHD3 NPEPL1 MECP2 PHKA2	8.33e-05	198	119	7	7204_DN
Drug	prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A	MYO1E PEX10 TEP1 CDK10 BMPR2 LRP2 ALDH5A1	8.33e-05	198	119	7	6552_UP
Drug	(1)-Nipecotic acid [498-95-3]; Down 200; 31uM; PC3; HT_HG-U133A	SH3TC2 PEX10 RCC1 MAP3K6 LIG1 MYOF DBR1	8.33e-05	198	119	7	7296_DN
Drug	U-62066 [87151-85-7]; Down 200; 1uM; MCF7; HT_HG-U133A	HSPG2 VPS39 CHD3 PIK3IP1 MYOF SERGEF MAP4K2	8.33e-05	198	119	7	3901_DN
Drug	Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; MCF7; HT_HG-U133A	MPP2 RNF31 CHD1L CDK10 MAP3K5 CSTF2T KLHL26	8.33e-05	198	119	7	1482_DN
Drug	Nisoxetine hydrochloride [57754-86-6]; Down 200; 13uM; HL60; HT_HG-U133A	MYO1E SPTLC2 PEX10 RCC1 FGF9 DNAJB2 ENOX2	8.33e-05	198	119	7	3117_DN
Drug	Domperidone maleate; Down 200; 7.4uM; MCF7; HT_HG-U133A	SPTLC2 MAP3K6 MECP2 MADD PHKA2 MYOF EIF2AK1	8.60e-05	199	119	7	5701_DN
Drug	S(-)Eticlopride hydrochloride [97612-24-3]; Down 200; 10.6uM; MCF7; HT_HG-U133A	MPP2 VPS39 SPTLC2 SNRK TEP1 MYOF LMO2	8.60e-05	199	119	7	5695_DN
Drug	Bucladesine sodium salt [16980-89-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A	RNF31 MYO1E MAP3K6 CDK10 PHKA2 MYOF ALDH5A1	8.87e-05	200	119	7	3483_UP
Drug	4,4'-dithiodipyridine	GFPT1 RYR3 CS GFPT2	8.96e-05	45	119	4	CID000075846
Drug	philanthotoxin	GRIA2 KARS1 CNDP2 GRIN3B	8.96e-05	45	119	4	CID000115201
Drug	cytosine	HLA-A TENT4A MECP2 LIG1 CS LMO2 H4C1 SLC38A3 DNMT1 HDAC2	1.09e-04	441	119	10	CID000000597
Drug	glutamate	CUL1 SPP1 GRIA2 CLIC6 BCS1L GFPT1 GGCX RYR3 CS KARS1 CNDP2 GFPT2 GRIN3B ALDH5A1 SLC38A3	1.50e-04	962	119	15	CID000000611
Drug	PA-J	RPL27A HLA-A	1.61e-04	4	119	2	CID000447261
Drug	AC1O5Y0I	GFPT1 GFPT2	1.61e-04	4	119	2	CID006442853
Drug	2-amino-2-deoxy-D-glucitol 6-phosphate	GFPT1 GFPT2	1.61e-04	4	119	2	CID000001554
Drug	lorazepam acetate	HLA-A LCT	1.61e-04	4	119	2	CID000017836
Drug	magnesium	MYO1E CILP MMP28 LAMA5 GRIA2 RYR3 DNAH1 PHKA2 LIG1 CS KARS1 GUCY2C SERGEF GRIN3B EIF2AK1 DNAH5 ALPG CKMT1A	1.78e-04	1325	119	18	CID000000888
Drug	(+/-)-Jasmonic Acid	CUL1 PEX10 SNRK MAP3K6 MAP3K5 FGF9	1.85e-04	158	119	6	CID000105087
Drug	NS 102	GRIA2 KARS1 GRIN3B	1.99e-04	22	119	3	CID005282252
Drug	cobalt-60	ARHGAP32 LAMA5 GRIA2 NPEPL1 GFPT1 RYR3 LIG1 GFPT2 ALPG	2.14e-04	390	119	9	CID000061492
Disease	level of Phosphatidylethanolamine (18:1_18:1) in blood serum	MYO1E SIK3 ADAM10	2.20e-05	14	118	3	OBA_2045142
Disease	hereditary sensory and autonomic neuropathy type 1 (implicated_via_orthology)	SPTLC3 SPTLC2	4.74e-05	3	118	2	DOID:0070162 (implicated_via_orthology)
Disease	Machado-Joseph disease (implicated_via_orthology)	GFPT1 GFPT2	9.46e-05	4	118	2	DOID:1440 (implicated_via_orthology)
Disease	level of Phosphatidylethanolamine (16:0_18:2) in blood serum	MYO1E SIK3 ADAM10	1.19e-04	24	118	3	OBA_2045136
Disease	amphetamine abuse (implicated_via_orthology)	MAP3K6 MAP3K5	2.35e-04	6	118	2	DOID:670 (implicated_via_orthology)
Disease	autosomal dominant polycystic kidney disease (biomarker_via_orthology)	SPP1 LRP2	3.29e-04	7	118	2	DOID:898 (biomarker_via_orthology)
Disease	graft-versus-host disease (implicated_via_orthology)	HLA-A HLA-G	3.29e-04	7	118	2	DOID:0081267 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	FLNA B4GAT1 SPP1 VPS39 SIK3 ADAM10 MAP3K6 DAP3 BMPR2 SBNO1 H4C1 PADI3 DNMT1	3.72e-04	1074	118	13	C0006142
Disease	Hereditary Sensory Autonomic Neuropathy, Type 1	SPTLC2 DNMT1	4.37e-04	8	118	2	C0020071
Disease	visual epilepsy (biomarker_via_orthology)	MECP2 MAP3K5 SLC38A3 HDAC2	4.76e-04	90	118	4	DOID:11832 (biomarker_via_orthology)
Disease	alopecia areata (is_marker_for)	DNMT1 HDAC2	6.99e-04	10	118	2	DOID:986 (is_marker_for)
Disease	triglyceride measurement, high density lipoprotein cholesterol measurement	HLA-A SIK3 ADAM10 DNAH1 SBNO1 MAP4K2	8.39e-04	274	118	6	EFO_0004530, EFO_0004612
Disease	free cholesterol to total lipids in small HDL percentage	TENT4A ADAM10 MADD	1.13e-03	51	118	3	EFO_0022285
Disease	alcohol use disorder (implicated_via_orthology)	CLIC6 RYR3 MADD MAP4K2 HDAC2	1.15e-03	195	118	5	DOID:1574 (implicated_via_orthology)
Disease	Mammary Carcinoma, Human	FLNA B4GAT1 SPP1 VPS39 ADAM10 DAP3 BMPR2 DNMT1	1.26e-03	525	118	8	C4704874
Disease	Mammary Neoplasms, Human	FLNA B4GAT1 SPP1 VPS39 ADAM10 DAP3 BMPR2 DNMT1	1.26e-03	525	118	8	C1257931
Disease	Mammary Neoplasms	FLNA B4GAT1 SPP1 VPS39 ADAM10 DAP3 BMPR2 DNMT1	1.29e-03	527	118	8	C1458155
Disease	vital capacity	HSPG2 SH3TC2 TENT4B MYO1E CLIC6 LCT CDK10 GFPT1 H4C1 PDIK1L ADAMTS15 LRP2 BOP1	1.36e-03	1236	118	13	EFO_0004312
Disease	membranous glomerulonephritis (biomarker_via_orthology)	MAP3K5 LRP2	1.40e-03	14	118	2	DOID:10976 (biomarker_via_orthology)
Disease	Breast Carcinoma	FLNA B4GAT1 SPP1 VPS39 ADAM10 DAP3 BMPR2 DNMT1	1.47e-03	538	118	8	C0678222
Disease	Spondyloepiphyseal Dysplasia	HSPG2 FLNA	1.83e-03	16	118	2	C0038015
Disease	Spondyloepiphyseal Dysplasia Tarda, X-Linked	HSPG2 FLNA	1.83e-03	16	118	2	C3541456
Disease	Schwartz-Jampel Syndrome, Type 1	HSPG2 FLNA	1.83e-03	16	118	2	C4551479
Disease	level of Phosphatidylethanolamine (16:0_20:4) in blood serum	MYO1E ADAM10	1.83e-03	16	118	2	OBA_2045137
Disease	central nervous system disease (implicated_via_orthology)	GRIA2 SMARCA1	1.83e-03	16	118	2	DOID:331 (implicated_via_orthology)
Disease	Schwartz-Jampel Syndrome	HSPG2 FLNA	1.83e-03	16	118	2	C0036391
Disease	Melnick-Needles Syndrome	HSPG2 FLNA	1.83e-03	16	118	2	C0025237
Disease	Van Buchem disease	HSPG2 FLNA	2.07e-03	17	118	2	C0432272
Disease	Intellectual Disability	GRIA2 CHD3 MECP2 CDK10 KARS1 LRP2 ALDH5A1	2.18e-03	447	118	7	C3714756
Disease	phospholipid measurement	MPP2 TENT4A SIK3 ADAM10	2.45e-03	140	118	4	EFO_0004639
Disease	osteochondrodysplasia (is_implicated_in)	HSPG2 FLNA	2.59e-03	19	118	2	DOID:2256 (is_implicated_in)
Disease	Osteochondrodysplasias	HSPG2 FLNA	2.59e-03	19	118	2	C0029422
Disease	Dyschondroplasias	HSPG2 FLNA	2.59e-03	19	118	2	C0013366
Disease	level of Phosphatidylethanolamine (18:0_20:4) in blood serum	MYO1E ADAM10	2.59e-03	19	118	2	OBA_2045140
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	HLA-A HLA-G SIK3 MADD	2.71e-03	144	118	4	EFO_0004611, EFO_0020943
Disease	Multiple Epiphyseal Dysplasia	HSPG2 FLNA	2.87e-03	20	118	2	C0026760
Disease	Schizophrenia	ARHGAP32 HLA-A VPS39 GRIA2 SBNO1 PDIK1L LRP2 PINK1 DNMT1 HDAC2	2.92e-03	883	118	10	C0036341
Disease	urate measurement	MPP2 SPP1 STAC3 CHD3 DNAH1 BMPR2 H4C1 LRP2 RBM8A MAP4K2	3.21e-03	895	118	10	EFO_0004531
Disease	sensory peripheral neuropathy, remission	MPP2 DCDC2C	3.80e-03	23	118	2	EFO_0009785, MONDO_0002321

Protein segments in the cluster

Peptide	Gene	Start	Entry
LLVDYRGYGKSEGEA	ABHD13	146	Q7L211
GYDLDGRRIYKPLRT	BOP1	151	Q14137
GGRGREISRDFAKLY	ARID3B	196	Q8IVW6
VGRSKYGRYGDNVEE	ARSH	281	Q5FYA8
RGLYDQYGEEGLKTG	DNAJB5	61	O75953
ATKNGILYRVGDGVY	DNMT1	926	P26358
GVLDASGDYRVYRGL	B4GAT1	71	O43505
TAQLGGKYRYGEILE	BPIFB4	96	P59827
RGGTFYVEPAERYIK	ADAM10	131	O14672
KVGYLVYAGGRRFLL	ADAMTS5	86	Q9UNA0
LIRPGRVDLKEYVGY	BCS1L	341	Q9Y276
VDTGRRYYVALNKDG	FGF9	156	P31371
AFKERDIYYGIGPRT	GLCE	331	O94923
IKKYLRAGYDGESIG	CLIC6	471	Q96NY7
RLVYDRETGKPKGYG	CSTF2	46	P33240
IRQRGYKGLIGDDNY	ADAMTS15	711	Q8TE58
YGLLSGGREGKFYRE	CFAP251	941	Q8TBY9
GCRLGEVGRRLYYKL	LMO2	61	P25791
SEGKAYSLGRAEYGR	RCC1	311	P18754
YSLGRAEYGRLGLGE	RCC1	316	P18754
VTGESKGLGYVRYLK	RBM45	156	Q8IUH3
YDGRGDSVVYGLRSK	SPP1	156	P10451
RFLGDKVTSYGGELR	HSPG2	996	P98160
LDRRTGYLKGYTLVE	RBM8A	106	Q9Y5S9
YEVRGETYLKGRGNE	GUCY2C	981	P25092
YERYGAVELSGAGRR	IRX6	136	P78412
RVGAGTYGDVYKARD	MAP4K2	21	Q12851
VIRAAQKDEYYRGGL	PEX10	11	O60683
DLGSDGRLLRGYEQY	HLA-G	126	P17693
KVSLRGKRIAEYSYG	PCDH19	756	Q8TAB3
YLKTGIRIKDGGSYV	TENT4B	326	Q8NDF8
DVVYALKRQGRTLYG	H4C1	86	P62805
RVYLYEGLLGRDKGS	MADD	1281	Q8WXG6
DKALYLSGYRIRLGS	ENOX2	176	Q16206
YLVERYLVDLISKGG	DDX60	66	Q8IY21
RLVLGKGTYGVVYAG	MAP3K6	651	O95382
YATRDDLIYTRIRGG	MAP3K6	1251	O95382
YKLTIVGDGKYGARD	GRIA2	461	P42262
IIKGNEEGYFGTRRL	FBLN2	1121	P98095
RVALAGEYGAVTYRK	PINK1	246	Q9BXM7
RDEELKTRGFGGIYG	NPEPL1	216	Q8NDH3
EDDKRRNYGGVYVGL	OCC1	31	Q8TAD7
KAYRLDGIDLRGYVA	LCT	1301	P09848
YAERKGAAYGLAGLV	GCN1	1391	Q92616
RGEGSRFGAIKRAYI	LRP2	4106	P98164
YEGNLYGTRIDSIRG	MPP2	446	Q14168
LGDRVSSYGGTLRYE	LAMA5	1701	O15230
AGIILGYSYKRGKDL	PIK3IP1	186	Q96FE7
YKRILGPDFGYVTRE	PADI3	381	Q9ULW8
IERYGIVDGIYRLSG	ARHGAP32	396	A7KAX9
YRLLSGGGRSKYAKI	FAM3B	76	P58499
YLKTGIRIKEGGAYI	TENT4A	426	Q5XG87
RRGEYIYTGNAKGKI	RBBP5	161	Q15291
ARDRKAYTVLLYGNG	ALPG	401	P10696
VLKYTAGEINYGGRV	DNAH1	3871	Q9P2D7
SLHDRIYVIGGYDGR	KLHL12	326	Q53G59
TVLRGRLYAIAGYDG	KLHL12	516	Q53G59
RLYISGGYGISVEDK	KLHL26	461	Q53HC5
GYRVVRKDGDLDGYA	LACTBL1	311	A8MY62
GLQRLEYRGYDSAGV	GFPT2	26	O94808
AILGKGGYGRVYKVR	EIF2AK1	171	Q9BQI3
KRDIYDRYGEAGAEG	DNAJB3	61	Q8WWF6
KLNRIGEGTYGIVYR	CDK10	41	Q15131
GGKYVAAGRERFKEL	DCDC2C	81	A8MYV0
DVTGRYTILIKYGGD	FLNA	1611	P21333
YKYERIDGGITGALR	CHD3	1101	Q12873
KREIYDRYGREGLTG	DNAJB2	61	P25686
RRECDEGRKGIYEIY	CUL1	146	Q13616
IYRNLYREGSGIGAI	CS	216	O75390
RGYSYERVDGSVRGE	CHD1L	386	Q86WJ1
GLKYVTYGNIRERVE	GALNTL5	401	Q7Z4T8
LELIGRGRYGAVYKG	BMPR2	206	Q13873
RGRYGAVYKGSLDER	BMPR2	211	Q13873
GRFLRGYRQDAYDGK	HLA-A	131	P04439
RNKYYGRGLSIEGFR	IP6K1	276	Q92551
YLGLAGVVKYRGVRI	DBR1	106	Q9UK59
RLVYDRETGKPKGYG	CSTF2T	46	Q9H0L4
DLRDIGAGKGKYYAV	HDAC2	211	Q92769
VIGAYLGRGKRAGRY	LIG1	761	P18858
ILYEEGIQGLYRGYK	SLC25A26	131	Q70HW3
GIQGLYRGYKSTVLR	SLC25A26	136	Q70HW3
KHYELVRELGKGTYG	SBK1	51	Q52WX2
GKGRTIAGIIYENYL	SBNO1	326	A3KN83
YGGRVTDDYDKRLLN	DNAH5	4251	Q8TE73
SGLKGDLAGRYYRLS	CKMT1A	196	P12532
KEGIAFLYSLYRDGR	ERCC6L	101	Q2NKX8
FLYSLYRDGRKGGIL	ERCC6L	106	Q2NKX8
IRKLEDGYFGGARVK	PHKA2	586	P46019
IDVVRSGYYKVLGKG	RPL27A	101	P46776
RKSGRSAGKYDVYLI	MECP2	111	P51608
ILFKGARYYVLARGG	MMP28	431	Q9H239
GDRVVLGKGTYGIVY	MAP3K5	681	Q99683
LGKGTYGIVYAGRDL	MAP3K5	686	Q99683
SLDKTIGLGTYGRIY	NRK	26	Q7Z2Y5
ELYLVGDGKYGALRD	GRIN3B	496	O60391
AIRYLLYGEKGTGKT	DAP3	121	P51398
LKEYVLTDGGRRVYS	USH2A	4961	O75445
RADYGQLGRKLETYE	SERGEF	291	Q9UGK8
SGVVGIRAYEQLGYR	SLC38A3	121	Q99624
GLGREGSKYGIDEYL	ALDH5A1	511	P51649
SYVKGGPLRDYQIRG	SMARCA1	176	P28370
RASGGKLIFYDLRGE	KARS1	136	Q15046
GLQRLEYRGYDSAGV	GFPT1	26	Q06210
PKYDLIREVGRGSYG	PDIK1L	6	Q8N165
ARIGYYEIDRTIGKG	SIK3	61	Q9Y2K2
YQIGRGRCKALTGYE	SH3TC2	266	Q8TF17
LRAYYGSLEDKRFGI	MSH4	446	O15457
SGGYIAGRKDLVDYL	SPTLC3	376	Q9NUV7
RGYDGKIAGLYDLDK	SNRK	6	Q9NRH2
GGKGDYERLDAIRFY	CILP	66	O75339
FTLVERDGKLYGRGS	CNDP2	116	Q96KP4
GCYRLVDYLEGIRKN	COA7	36	Q96BR5
RKRAEGLSGYAVRYL	TEPP	206	Q6URK8
AVQGGRDVLRLYGYT	RNF31	111	Q96EP0
LVSAIYGRGIAYGKK	TTC13	176	Q8NBP0
VKITYRDGRTGELGY	GGCX	411	P38435
RVAVGYRADGIRIYK	TEP1	1941	Q99973
GGRYEEYRGRLLDAN	RBMXL3	666	Q8N7X1
RYKLTVGKYRGTAGD	TNN	1186	Q9UQP3
GYIGGKKELIDYLRT	SPTLC2	386	O15270
RKVINKYGDLYGAER	RYR3	4556	Q15413
VKLRGGSKGLVRFYY	PLCH2	56	O75038
GRGTLYKYRPEEVDI	PLEKHA5	621	Q9HAU0
AGGYVKVYTGRKVGL	STAC3	341	Q96MF2
FKRDYYLIRVDGKGS	VPS39	181	Q96JC1
GLKENIRVRRAGYAY	MYO1E	611	Q12965
RLLDLYASGERRAYG	MXRA8	221	Q9BRK3
LSEDGSRIRYGGRDY	MYOF	1691	Q9NZM1
LHIGKVVLGDRGYYR	MYBPC2	121	Q14324
VVLGDRGYYRLEVKA	MYBPC2	126	Q14324